← Open Payments lookup

JASBIR BISLA: Open Payments

NPI 1528058500 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,211 in 191 payments from 18 companies in 2025. Trend: 2023 $2,581 · 2024 $3,088 · 2025 $3,211

Food & beverage: $3,211
CompanyPaymentsAmount
ABBVIE INC.53$780
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)23$408
Lundbeck LLC17$308
Otsuka America Pharmaceutical, Inc.13$254
Neurocrine BioSciences, Inc.13$227
Vanda Pharmaceuticals Inc.15$202
Alkermes, Inc.10$194
Janssen Pharmaceuticals, Inc8$166
E.R. Squibb & Sons, L.L.C.8$143
Takeda Pharmaceuticals U.S.A., Inc.10$139

Products named: VRAYLAR, REXULTI, CAPLYTA, INGREZZA, FANAPT, ARISTADA, COBENFY, TRINTELLIX.

Industry payments across AZ — which companies pay providers there.